Awardee OrganizationRUTGERS, THE STATE UNIV OF N.J.
Description
Abstract Text
DESCRIPTION (provided by applicant): Gene expression in eukaryotes is often
under the control of multiple nuclear proteins that work in combination to
regulate transcription. The combined interactions between these proteins often
create a new form of regulatory activity that is distinct from either protein
alone. The interactions between proteins dictate which DNA target sites are
bound and therefore which sets of genes are regulated. In some cases, these
protein interactions also influence whether a regulatory protein functions as a
transcriptional activator or repressor. This form of regulation, often referred
to as the combinatorial control of transcription, is widely used to control
gene expression under specific cellular or developmental conditions.
Understanding the mechanism of how these proteins interact in different
combinations, and how these interactions determine their activity and
specificity of the complex will provide insight into the regulation of many
developmental and cellular processes. We have chosen two regulatory systems in
the yeast Saccharomyces cerevisiae to investigate the mechanism of
combinatorial control of transcription.
The alpha2 repressor, a homeodomain protein, interacts with the Mcm1 and a1
protein to turn off two different sets of cell type specific-genes in yeast. We
have previously investigated how alpha2 recognizes the DNA on its own, and how
the interactions with Mcml and a1 influence the target specificity of the
complex. We now propose to investigate how the a1-alpha2 complex binding to
multiple sites in the HO promoter function to repress transcription of the gene
(Specific aim 1). The HO gene contains a large and complex promoter with a wide
array of different regulatory sites and serves as a good model system for the
regulation of developmental genes in higher eukaryotes.
The yeast Mcm1 protein is a transcriptional regulatory factor with sequence
similarity to the MADS-box DNA-binding domains of the mammalian serum response
factor (SRF) and Myocyte Enhancer Factor 2A (MEF2A) proteins. The MADS-box
domain of Mcm1 interacts with at least five different cofactors to regulate
different sets of genes that are required for cellular processes ranging from
cell mating type and arginine metabolism to cell-cycle control. We propose to
investigate how Mcm1 interacts with the MATalpha1 protein and how this
interaction alters the conformation of the protein to activate transcription
(Specific aim 2). We propose to investigate the interactions of Mcm1 with SFF,
a complex of proteins including the forkhead protein, Fkh2, that regulate
cell-cycle specific genes (Specific aim 3). Finally, we plan to investigate the
interactions of Mcm1 with ArgR, a complex of three proteins that regulate genes
involved in arginine metabolism. The information we learn about the
interactions between these different classes of proteins will be relevant to
more complex systems in higher eukaryotes and will provide insight on how these
proteins function to regulate development.
No Sub Projects information available for 5R01GM049265-11
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM049265-11
Patents
No Patents information available for 5R01GM049265-11
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM049265-11
Clinical Studies
No Clinical Studies information available for 5R01GM049265-11
News and More
Related News Releases
No news release information available for 5R01GM049265-11
History
No Historical information available for 5R01GM049265-11
Similar Projects
No Similar Projects information available for 5R01GM049265-11